NasdaqCM:SSKN

Stock Analysis Report

Executive Summary

STRATA Skin Sciences, Inc., a medical technology company, focuses on the therapeutic and aesthetic dermatology market.

Snowflake

Fundamentals

Adequate balance sheet with reasonable growth potential.

Risks

  • STRATA Skin Sciences has significant price volatility in the past 3 months.
  • STRATA Skin Sciences's last earnings update was 305 days ago.
  • STRATA Skin Sciences is covered by less than 3 analysts.

Similar Companies

Share Price & News

How has STRATA Skin Sciences's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

12.7%

NasdaqCM:SSKN

-1.2%

US Medical Equipment

1.2%

US Market


1 Year Return

-34.1%

NasdaqCM:SSKN

8.7%

US Medical Equipment

1.7%

US Market

SSKN underperformed the Medical Equipment industry which returned 8.7% over the past year.

SSKN underperformed the Market in United States of America which returned 1.7% over the past year.


Share holder returns

SSKNIndustryMarket
7 Day12.7%-1.2%1.2%
30 Day-3.8%1.4%4.9%
90 Day1.8%4.8%3.7%
1 Year-34.1%-34.1%9.6%8.7%3.9%1.7%
3 Year-17.0%-17.0%70.8%65.5%47.2%37.7%
5 Year-75.3%-75.3%130.4%104.1%60.0%42.4%

Price Volatility Vs. Market

How volatile is STRATA Skin Sciences's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is STRATA Skin Sciences undervalued based on future cash flows and its price relative to the stock market?

2.32x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

STRATA Skin Sciences's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

STRATA Skin Sciences's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

STRATA Skin Sciences is loss making, we can't compare its value to the US Medical Equipment industry average.

STRATA Skin Sciences is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for STRATA Skin Sciences, we can't assess if its growth is good value.


Price Based on Value of Assets

STRATA Skin Sciences is good value based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is STRATA Skin Sciences expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

90.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

STRATA Skin Sciences's revenue is expected to grow by 14.9% yearly, however this is not considered high growth (20% yearly).

STRATA Skin Sciences's earnings are expected to grow significantly at over 20% yearly.

STRATA Skin Sciences's revenue growth is expected to exceed the United States of America market average.

STRATA Skin Sciences's earnings growth is expected to exceed the United States of America market average.

STRATA Skin Sciences's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if STRATA Skin Sciences will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has STRATA Skin Sciences performed over the past 5 years?

16.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

STRATA Skin Sciences does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.

Unable to compare STRATA Skin Sciences's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare STRATA Skin Sciences's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if STRATA Skin Sciences has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if STRATA Skin Sciences has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if STRATA Skin Sciences improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is STRATA Skin Sciences's financial position?


Financial Position Analysis

STRATA Skin Sciences is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

STRATA Skin Sciences's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

STRATA Skin Sciences's level of debt (22.1%) compared to net worth is satisfactory (less than 40%).

Unable to establish if STRATA Skin Sciences's debt level has increased without past 5-year debt data.

Debt is well covered by operating cash flow (50.1%, greater than 20% of total debt).

Unable to confirm if the interest payments on STRATA Skin Sciences's debt are well covered by earnings due to lack of past financial data.


Balance Sheet

Low level of unsold assets.

Debt is covered by short term assets, assets are 3x debt.


Next Steps

Dividend

What is STRATA Skin Sciences's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate STRATA Skin Sciences's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate STRATA Skin Sciences's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as STRATA Skin Sciences has not reported any payouts.

Unable to verify if STRATA Skin Sciences's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as STRATA Skin Sciences has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of STRATA Skin Sciences's salary, the management and board of directors tenure and is there insider trading?

2.8yrs

Average management tenure


CEO

Dolev Rafaeli (55yo)

1.4yrs

Tenure

0

Dr. Dolev Rafaeli, Ph.D., has been Chief Executive Officer and Director of Strata Skin Sciences, Inc. since May 29, 2018 and also serves as its President. Dr. Rafaeli served as Interim Chief Executive Offi ...


Management Age and Tenure

2.8yrs

Average Tenure

58.5yo

Average Age

The tenure for the STRATA Skin Sciences management team is about average.


Board Age and Tenure

1.3yrs

Average Tenure

65yo

Average Age

The average tenure for the STRATA Skin Sciences board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Darrell Rigel (68yo)

    Chief Medical Advisor

    • Tenure: 5.9yrs
  • Mike Stewart (62yo)

    Independent Consultant

    • Tenure: 2.8yrs
    • Compensation: US$732.90k
  • Jay Sturm (63yo)

    Corporate Counsel & Corporate Secretary

    • Tenure: 0yrs
  • Dolev Rafaeli (55yo)

    CEO, President & Director

    • Tenure: 1.4yrs
  • Matt Hill (50yo)

    VP & CFO

    • Tenure: 1.3yrs
  • Nikolai Kabelev (43yo)

    Vice President of Research & Development

    • Tenure: 11.7yrs
    • Compensation: US$370.90k
  • Shmuel Gov

    Executive VP & GM

    • Tenure: 0yrs
  • Keith Simeone

    Vice President of Sales

    • Tenure: 0yrs

Board Members

  • Dan Lufkin (86yo)

    Director Emeritus

    • Tenure: 9.4yrs
    • Compensation: US$28.62k
  • David Gill (64yo)

    Director

    • Tenure: 1.3yrs
  • Sam Navarro (63yo)

    Director

    • Tenure: 5.5yrs
    • Compensation: US$104.03k
  • Homi Shamir (65yo)

    Director

    • Tenure: 1.3yrs
  • Uri Geiger (51yo)

    Chairman of the Board

    • Tenure: 1.3yrs
  • R. Anderson (68yo)

    Member of Scientific Advisory Board

    • Tenure: 2.3yrs
    • Compensation: US$10.25k
  • Dolev Rafaeli (55yo)

    CEO, President & Director

    • Tenure: 1.4yrs
  • LuAnn Via (65yo)

    Independent Director

    • Tenure: 7.4yrs
    • Compensation: US$63.53k
  • Samuel, Milky Rubinstein (79yo)

    Independent Director

    • Tenure: 1.3yrs

Company Information

STRATA Skin Sciences, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: STRATA Skin Sciences, Inc.
  • Ticker: SSKN
  • Exchange: NasdaqCM
  • Founded: 1989
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$81.562m
  • Shares outstanding: 35.46m
  • Website: https://www.strataskinsciences.com

Number of Employees


Location

  • STRATA Skin Sciences, Inc.
  • 100 Lakeside Drive
  • Suite 100
  • Horsham
  • Pennsylvania
  • 19044
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SSKNNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDOct 2005
E2OMDB (Deutsche Boerse AG)YesCommon StockDEEUROct 2005

Biography

STRATA Skin Sciences, Inc., a medical technology company, focuses on the therapeutic and aesthetic dermatology market. The company operates through three segments: Dermatology Recurring Procedures, Dermato ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/15 00:28
End of Day Share Price2019/09/13 00:00
Earnings2018/09/30
Annual Earnings2017/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.